Amgen teams up for Chinese joint venture
Thousand Oaks-based biotech giant Amgen has teamed up with a Chinese company for a joint venture to sell its colorectal cancer drug Vectibix there. Zhejiang Beta Pharma will be 51 percent owner of the the new firm, which will be known as Amgen-Beta Pharmaceuticals. The deal is still subject to approval from Chinese authorities. Amgen’s Read More →
Read More →U.S. cracks down on Chinese solar
Handing a victory to SolarWorld Industries, which maintains offices in Camarillo, the U.S. Department of Commerce has issued a preliminary ruling that would impose a series of small tariffs on solar panels imported from China. According to a press release from a coalition of panel makers that supported the SolarWorld dumping case, the March 20 Read More →
Read More →Op/ed: Camarillo is a battleground in fight for U.S. solar jobs
Until this level playing field returns, we must continue to fight for America’s renewable-energy industry.
Read More →
SB architects look far afield in face of regional slowdown
Like architects elsewhere, Clay Aurell and business partner Josh Blumer of AB Design Studio found that business in California is spottier than before — development has slowed, which means less work for architects here.
Read More →Editorial: To win green jobs, foster innovation
How can the United States compete in a game that’s rigged? That is the question facing the solar energy manufacturing industry in this country.
Read More →Guest op/ed: Lack of consistency, standards holding Chinese progress down
What really struck me on my most recent business trip to China is the lack of consistency and adherence to standards.
Read More →Software firm asks court to let it sue China
A Santa Barbara firm’s case that determine whether U.S. firms can sue the Chinese government and its contractors.
Read More →
Sponsored content:
2015-2016 Giving Guide
